An assessment of neovascular AMD activity


Looking at an activity socring system to define lesions associated with wet AMD by quantifying their activity to determine the need for treatment.

Key Points


Activity scoring system

The proposed ASS is based on the well-known and widely used signs and findings of active CNV:

Apart from FA staining pattern, all of the other assessments are based on the changes in each parameter (same-baseline/increased/decreased) and given a number to define the activity. At the end of the assessment, the numbers are totalled and an activity score is obtained.

Activity scores (AS) can range between 0 and 14. We believe that a CNV lesion with AS of 6–7 or more requires treatment and <6 does not. We are currently compiling a paper to more accurately determine the cut off AS to separate those lesions that need treatment and those that do not.

Related Videos
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Giulia Corradetti, MD, discusses her presentation "Functional Microperimetric Correlates of OCT Structures Features in Intermediate AMD"
At this year's ARVO meeting, Paolo Silva, MD, presented data on Protocol AA on behalf of the DRCR Retina Network
Baruch Kuppermann, MD, PhD
At this year's ARVO meeting, Qinqin Zhang, PhD, presented a poster titled "A unified deep learning model for geographic atrophy segmentation: Adaptable to SS-OCT and SD-OCT data with multiple scan patterns."
Ash Abbey, MD, shares 36-month data from the GALE study of pegcetacoplan
© 2024 MJH Life Sciences

All rights reserved.